One of the world's largest life science investors ($60B+ AUM). Healthcare IT, digital health, and life sciences across Europe, US, and Asia from Singapore, Boston, and San Francisco offices.
Novo Holdings has a Singapore office and an active mandate to back healthcare IT in Asia. MOVO-X operates in Singapore (PDPA-SG / NEHR compliant), Malaysia (KPJ discussions, 30+ hospitals), Canada, Morocco, and Spain. Five countries, four regulatory regimes — the kind of validated multi-market healthcare infrastructure that earns a $60B life science fund's attention. Novo's portfolio in health data interoperability (Availity) maps directly to MOVO-X's FHIR R4 architecture.
Malaysia's largest private hospital group. Bursa-listed. JCorp majority. 30+ hospitals across 13 Malaysian states. Advanced discussions underway — significant potential for enterprise-wide AI triage, queue management, and kiosk check-in deployment.
Multi-tenant SaaS active across Quebec and Ontario clinic networks. PIPEDA + Law 25 compliant. Interac and Stripe payments. Architecture validated across clinic groups.
Full PDPA (SG), HBRA, and NEHR integration architecture complete. PayNow + NETS + Stripe. English and Mandarin. Strong pipeline potential with Singapore hospital groups.
We'd love to walk you through our product, architecture, and pipeline. If healthcare AI in ASEAN fits your mandate, we should have a conversation.